High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy by Al-Mekhlafi, A.M. et al.
RESEARCH Open Access
High frequency of Plasmodium falciparum
chloroquine resistance marker (pfcrt T76
mutation) in Yemen: An urgent need to
re-examine malaria drug policy
Abdulsalam M Al-Mekhlafi1*, Mohammed AK Mahdy1,2, Hesham M Al-Mekhlafi1,2, Ahmed A Azazy2 and
Mun Yik Fong1
Abstract
Background: Malaria remains a significant health problem in Yemen with Plasmodium falciparum being the
predominant species which is responsible for 90% of the malaria cases. Despite serious concerns regarding
increasing drug resistance, chloroquine is still used for the prevention and treatment of malaria in Yemen. This
study was carried out to determine the prevalence of choloroquine resistance (CQR) of P. falciparum isolated from
Yemen based on the pfcrt T76 mutation.
Methods: A cross-sectional study was carried out among 511 participants from four governorates in Yemen. Blood
samples were screened using microscopic and species-specific nested PCR based on the 18S rRNA gene to detect
and identify Plasmodium species. Blood samples positive for P. falciparum were used for detecting the pfcrt T76
mutation using nested-PCR.
Results: The prevalence of pfcrt T76 mutation was 81.5% (66 of 81 isolates). Coastal areas/foothills had higher
prevalence of pfcrt T76 mutation compared to highland areas (90.5% vs 71.8%) (p = 0.031). The pfcrt T76 mutation
had a significant association with parasitaemia (p = 0.045). Univariate analysis shows a significant association of
pfcrt T76 mutation with people aged > 10 years (OR = 9, 95% CI = 2.3 - 36.2, p = 0.001), low household income
(OR = 5, 95% CI = 1.3 - 19.5, p = 0.027), no insecticide spray (OR = 3.7, 95% CI = 1.16 - 11.86, p = 0.025) and not
sleeping under insecticide treated nets (ITNs) (OR = 4.8, 95% CI = 1.38 - 16.78, p = 0.01). Logistic regression model
confirmed age > 10 years and low household income as predictors of pfcrt T76 mutation in Yemen P. falciparum
isolates.
Conclusions: The high prevalence of pfcrt T76 mutation in Yemen could be a predictive marker for the prevalence
of P. falciparum CQR. This finding shows the necessity for an in-vivo therapeutic efficacy test for CQ. P. falciparum
CQR should be addressed in the national strategy to control malaria.
Background
Malaria remains the major cause of disease and death in
the world, especially among children and pregnant
women [1-4]. Malaria treatment depends on the type and
severity of the disease. Chloroquine (CQ) is safe, inex-
pensive, and used for the treatment of uncomplicated
malaria [5]. However, since the early 1960s, resistance of
P. falciparum to chloroquine has been rising [6-10]. The
P. falciparum CQ resistance transporter (pfcrt) T76
mutation is the most important molecular marker
[11-18]. This point of mutation has shown strong corre-
lation with in vivo and in vitro CQ resistance making
pfcrt T76 mutation a significant marker for the prediction
of the spread of P. falciparum CQ resistance
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In Yemen, where 60% of the total population live in
malarious areas, the disease remains a significant health
problem but chloroquine is still used [10,24]. Three
Plasmodium species (P. falciparum, P. vivax and P.
malariae) are reported in Yemen with P. falciparum
being the predominant species [24-29]. The CQR pro-
blem is constantly growing since the detection of the
first indigenous cases of P. falciparum CQR in 1989
[24]. Over the past two decades, few studies have been
carried out to examine antimalarial drug efficacies in
Yemen, both in vivo and in vitro [24,25,30]. However,
no information about antimalarial drug resistance is
available from highland areas which are endemic for
malaria in Yemen. This study is the first study which
aims to determine the prevalence of pfcrt 76T mutation
among patients with P. falciparum in Yemen and to
compare the prevalence of pfcrt 76T mutation between
highland and coastal areas/foothills.
Materials and methods
Study areas and population
The present study was conducted in four governorates
of Yemen (Figure 1). Taiz and Hodeidah represent the
mountainous hinterland and coastal areas, respectively.
Rymah and Dhamar represent the highland areas. The
peak time of malaria transmission in the coastal areas
occurs in winter (October-April), while in the western
mountains, the peak occurs in the summer (May-
September). In the highlands areas (> 2000 metres
above sea level), the transmission of malaria occurs
throughout the year [31]. Anopheles arabiensis is the
main vector in the country but A. culicifacies plays an
important role in the transmission of malaria in the
coastal areas. A. sergenti has also been reported in the
mountainous hinterland and highland areas [31]. In the
western costal area, temperatures are very high and
occasionally exceed 54°C with irregular heavy torrents of
rainfall. The mountainous hinterland receives from
about 1,000-1,500 millimetres of rain each year with
mild temperature in summer and cold in the winter
with average temperature of 21°C. The climate in the
highlands is characterized by a temperate, rainy summer
with an average temperature of 20°C. The minimum
sample size required for this study (246 subjects) was
calculated based on previous prevalence reported in
Yemen with 5% significance level and confidence level
of 95% [24,27,32].
Data collection
A total of 511 blood samples were collected between
June 2008 and March 2009. Blood samples were col-
lected through finger pricks from febrile patients attend-
ing public and private health centres and hospitals. Thin
and thick blood films were prepared and blood drops
were spotted on Whatman filter papers 3 MM (What-
man International Ltd., Maidstone, England).
Figure 1 A geographic map shows study area.
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Demographic and socioeconomic information of partici-
pants were collected using a pre-tested questionnaire.
Microscopic examination
Thick and thin blood films were prepared, air dried
and stained with diluted Giemsa stain (1:20, vol/vol)
for 20 min. All slides were examined by local micro-
scopists for malaria parasites. Re-examination and spe-
cies level identification were performed in a blind
manner, in two different laboratories by two expert
microscopists following standard and quality-controlled
procedures. Parasitaemia levels were obtained from
thick smears by counting the number of asexual para-
sites against 200 leucocytes and expressed per micro
liter of blood using an assumed leukocyte count of
8000 wbc/ul.
Molecular identification of Plasmodium species and pfcrt
T76 mutation
Parasite genomic DNA was extracted from the blood
collected on filter paper. DNA was extracted using
QIAgen DNA Mini Kit for Blood and Tissue (QIA-
GEN, Germany) according to the manufacturer ’s
instructions. Nested PCR assays based on 18S rRNA
gene were used to detect and identify the Plasmodium
species as mentioned previously [33]. The detection of
the pfcrt T76 mutation was done according to the pro-
tocol described previously [7,34]. The allele-specific
polymerase chain reaction (AS-PCR) was used. Nest 1
was carried out using 250 nM of TCRP1 (5’-CCG TTA
ATA ATA AAT ACA CGC AG-3’) and TCRP2 (5’-
CGG ATG TTA CAA AAC TAT AGT TAC C-3’) pri-
mers in a 25 μl reaction mixture containing 1X PCR
buffer (iNtRON), 2.5 mM MgCl2 (iNtRON), 0.2 mM of
dNTPs (iNtRON), 1 U of Taq polymerase (iNtRON)
and 4 μl of extracted DNA. Initial denaturation was
carried out for 3 minutes at 94°C followed by 30 cycles
of denaturing for 30 seconds at 94°C, annealing for 30
seconds at 56°C and extension at 60°C for 1 minute.
The final extension was carried out at 60°C for 3
minutes.
For allele-specific PCR, 2 μl of the nest 1 product was
used in a volume 25 μl reaction containing 1X PCR buf-
fer (iNtRON), 1.5 mM MgCl2 (iNtRON), 0.2 mM of
dNTPs (iNtRON), and 1 U of Taq polymerase
(iNtRON). The primer TCRP3 (5’-TGA CGA GCG
TTA TAG AG-3’) was used with a mutant-specific pri-
mer TCRP4 m (5’-GTT CTT TTA GCA AAA ATT G-
3’) or a wild-type-specific primer TCRPw (5’-GTT CTT
TTA GCA AAA ATT T-3’). The PCR conditions were
performed same as for nest 1, except that the annealing
was 47°C, extension was 64°C and the number of cycles
were 25. The PCR products were resolved by electro-
phoresis in a 1.5% agarose gel.
Data analysis
Data analysis was performed by SPSS version 11.5 (SPSS
Inc., Chicago, IL, USA). Chi-square test (or Fisher’s
exact test when required) was used to test the differ-
ences between groups. For univariate analysis, odds ratio
and 95% confidence interval were used. A value of P <
0.05 was considered statistically significant. Those vari-
ables that showed significance with P < 0.05, were used
to develop a stepwise forward logistic regression model.
Ethical approval
The protocol of this study was approved by Sana’a Uni-
versity, Republic of Yemen and participants with febrile
illness who gave written informed consents were
included in this study.
Results
Demographic characteristic
A total of 511 participants (268 males and 242 females),
with a median age of 20 years and interquartile range of
22 years voluntarily participated in this study. The basic
characteristics of the participants are shown in Table 1.
Out of 511 blood specimens, malaria parasites were
detected in 78 (15.3%) by microscopic examination for
the thin and thick blood films as compared to 86
(16.8%) by nested PCR amplification of the 18S rRNA
gene. Majority of the malarial infections were due to P.
falciparum (80.3%).
Prevalence and distribution
Of the 81 P. falciparum positive samples, pfcrt 76T
mutation was detected in 66 (81.5%). Wild type was
detected in 15 (18.5%) and 10 (10.3%) were mixed
(Figure 2). The pfcrt 76T mutation was detected in all
governorates where the study was conducted. Prevalence
was significantly higher in coastal areas/foothills (90.5%)
as compared to highland areas (71.8%) (c2 = 4.67, P =
0.031). There was a significant association between pfcrt
76T mutation and parasitaemia (Fisher exact test, P =
0.045) (Figure 3).
Univariate and multivariate analysis
The associations of the prevalence of pfcrt 76T muta-
tions with the potential risk factors are presented in
Table 2. The pfcrt 76T mutation was significantly
associated with age group > 10 years (OR = 9.2, 95%
CI = 2.3-36.2, P = 0.001), low household income (OR
= 5.0, 95% CI = 1.3-19.5, P = 0.027), not spraying
insecticides (OR = 3.7, 95% CI = 1.16-11.86, P =
0.025) and not using ITNs (OR = 4.8, 95% CI = 1.38-
16.78, P = 0.01). By using logistic regression analysis,
the age group > 10 years and low household income
were retained as significant factors associated with
pfcrt 76T mutations.
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Discussion
Malaria is an endemic disease in Yemen which causes
thousands of deaths per year and almost two-thirds of
the people are at risk of acquiring the disease. Yemen
has not achieved significant decrease in the annual num-
ber of malaria cases as compared to other countries in
the region such as Iraq, Iran and Saudi Arabia which
have entered the malaria elimination or pre-elimination
stage [10]. P. falciparum is the predominant species in
Yemen, accounted for about 90% of malaria cases
[24,25,27,28,31,35]. This study depends on the detection
of a single point mutation in codon 76T of the pfcrt
gene, which has shown a strong and significant associa-
tion with in vitro and in vivo susceptibility to chloro-
quine [11-18].
The study showed high prevalence of pfcrt 76T muta-
tion in Yemen with coastal areas/foothills having higher
rate as compared to highland areas. This finding is con-
sistent with previous in vivo and in vitro studies carried
out in coastal areas/foothills [24,30]. In Hodeidah
(coastland areas), in vivo study found CQR in 71% of P.
falciparum-infected patients[25]. In in vitro study, car-
ried out in the same area using mark III technique,
reported 47% of CQR [30]. CQR was also reported from
Taiz (foothills areas) using a 7-day in vivo test [24].
However, there are no previous reports of CQR from
highland areas endemic for malaria in Yemen. The pfcrt
76T mutation has been considered as a key determinant
of chloroquine treatment failure both in vitro and in the
field [11-18]. Thus, the high prevalence of this marker
warrants public health awareness on the emergence and
spread of P. falciparum CQR in Yemen.
The present study found significant association of
pfcrt 76T mutation with moderate/low parasitaemia.
The relationship between pfcrt 76T mutation and
malaria severity is a controversial issue. Studies carried
Figure 3 Prevalence of pfcrt T76 mutation in Plasmodium
falciparum Yemen isolates in different endemic areas and
according to parasitaemia.
Figure 2 Prevalence of pfcrt T76 mutation in Plasmodium
falciparum Yemen isolates.
Table 1 Characteristic of study population
Variable n %
Age (years)
≤ 10 147 29
>10 364 71
Sex
Male 268 47
Female 241 53
Residence
Rural 275 54
Urban 234 46
Household income
High (≥ 100 US dollars/month) 187 37
Low (< 100 US dollars/month) 322 63
Quality of housing*
Good 456 90
Bad 52 10
Clothes
Long (covering arms and legs) 298 59
Short 208 41
Insecticide spray
Yes 152 30
No 353 70
Using ITNs
Yes 152 30
No 356 70
Water stream (≤ 200 m of household)
Yes 167 33
No 340 67
Closing house windows
Yes 327 64
No 181 36
n: number of subjects
*Good housing condition was defined as being complete, made up of stones/
bricks with no opening or holes. Bad housing condition did not have all these
characteristics
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out in Sudan [36] and Congo [37] showed no significant
association between severe malaria and frequency of
pfcrt 76T mutation. However, significant association of
pfcrt 76T mutation with severity of malaria was reported
from India [38] and Mali [21]. The reason for these
observations is still unclear [21].
Logistic regression analysis of socio-economic factors
indicated a significant association of pfcrt 76T mutation
with the age group > 10 years and low household
income. These findings may be explained by the fact
that these factors may increase human exposure to mos-
quito bites leading to high intensity of malaria transmis-
sion. Adults, especially in the coastal areas/foothill
during the hot season, wear short clothes and may sleep
in the courtyard of the house. Low household income
plays a significant role in malaria transmission since it
affects housing, living place, prevention and treatment
[39-41]. The correlation between intensity of malaria
transmission and genetic diversity, which may provide a
mechanism for the emergence of drug resistance in P.
falciparum population, has been reported [42].
Conclusions
Our study reveals high prevalence of pfcrt 76T point
mutation in Yemen, suggesting high prevalence and
spread of P. falciparum CQR. This should be taken into
consideration in the national strategy to control malaria.
Data from this study support an urgent need to re-
examine malaria drug policy. Continuous surveillance to
detect emergence of anti-malarial drug resistance is
essential in Yemen.
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